The largest database of trusted experimental protocols

T rex 293 cells

Manufactured by Thermo Fisher Scientific
Sourced in United States

The T-REx-293 cells are a human embryonic kidney cell line that has been engineered to express the tetracycline repressor protein (TetR). This cell line is designed to enable inducible gene expression, allowing for the controlled expression of genes of interest in response to the addition of tetracycline or its derivative, doxycycline.

Automatically generated - may contain errors

61 protocols using t rex 293 cells

1

Generation of Tetracycline-Inducible Reporter Cell Line

Check if the same lab product or an alternative is used in the 5 most similar protocols
T-REx-293 cells (Invitrogen, Carlsbad CA) expressing the tetracycline
repressor protein (TetR) were transfected with inducible luciferase and EGFP
reporter genes. To accomplish this, the T-REx-293 cells were grown in
Dulbecco’s Modified Eagle Medium (DMEM) containing 10% Tet-approved FBS
and 5μg/mL of blasticidin and transfected using the Lipofectamine 2000
reagent according to the manufacturer’s protocol (ThermoFisher).
Forty-eight hours after transfection, the cells were split into fresh medium
with the addition of 200μg/mL of zeocin for stable cell line selection.
Single foci were selected and expanded. After induction with doxycycline
(2μg/mL), clones were harvested to test for tetracycline-inducible EGFP
and luciferase expression using fluorescent microscopy and a luciferase reporter
assay. Cell clones with highest EGFP and luciferase expression upon induction
were amplified. This EGFP and luciferase dual expression cell line was named as
reporter-only cell line (Figure 1).
+ Open protocol
+ Expand
2

Inducible NOTCH3 Expression in HEK293 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
We established stable HEK293 cell lines in which the expression of NOTCH3 was inducible using the tetracycline regulatory system because it was known that the expression of NOTCH3 in vascular SMCs caused excessive cell death as early as 2 days after transfection (Takahashi et al. 2010 (link)). T-REx 293 cells (Invitrogen, Carlsbad, CA) were grown in high glucose DMEM (Sigma, St Louis, MO) supplemented with 10% fetal bovine serum (Gibco, Grand Island, NY), 2 mmol/L l-glutamine, and 5 μg/mL blasticidin (Gibco). The wild-type and mutant NOTCH3 constructs were transfected into T-REx 293 cells using Lipofectamine 2000 reagent (Invitrogen). After 48 h, cells were selected in the presence of 100 μg/mL Zeocin and 5 μg/mL blasticidin-S (Invitrogen). After treatment with tetracycline (Tet; 2 μg/mL) for 24 h, the expression level of NOTCH3 was determined by western blotting using AbN2. Stable cell lines were maintained in high glucose DMEM-containing 10% fetal bovine serum, 5 μg/mL Zeocin, and 5 μg/mL blasticidin-S.
+ Open protocol
+ Expand
3

Generating a Packaging Cell Line

Check if the same lab product or an alternative is used in the 5 most similar protocols
At Baxter, 293 T‐REx cells (Invitrogen) were cultivated in Dulbecco's modified Eagle's medium (DMEM, Invitrogen) with 10% fetal calf serum (Invitrogen), 2 mM glutamine (Invitrogen), and 5 mg/l blasticidin S (Invitrogen); 293 T‐REx cells were transfected by electroporation using 5 μg of pY‐Rev, following manufacturer's instructions (PEQLAB, Microporator MP‐100), selected in the presence of 5 mg/l blasticidin S and 50 mg/l hygromycin B (Invivogen); 293 T‐REx Rev cells were then transfected as above with pY‐Gag/Pol plasmid, selected in the presence of 5 mg/l blasticidin S, 50 mg/l hygromycin B, 2.5 mg/l Geneticin (Invitrogen) and were then transfected with pY‐VSV.G plasmid as above and selected in the presence of 5 mg/l blasticidin S, 50 mg/l hygromycin B, 2.5 mg/l Geneticin, 5 mg/l puromycin (Sigma) to generate the packaging cell line.
+ Open protocol
+ Expand
4

Generation and Characterization of Stable P-Cell Line

Check if the same lab product or an alternative is used in the 5 most similar protocols
T-REx-293 cells (Invitrogen) were maintained in T-REx-293 culture medium, which consisted of DMEM (Gibco 41966) supplemented with 10% FBS (Biosera) and 5 μg/mL blasticidin (Gibco), at 37 °C and 5% CO2. Cells were transfected in 24-well plates using 1 μg plasmid and 2 μL lipofectamine 2000 (Invitrogen), in 100 μL Opti-MEM (Gibco) for each well. Cells were then selected using 800 μg/mL G418 (Sigma) for 2 weeks. Stably transfected cells were maintained and tested in T-REx-293 culture medium with 200 μg/mL G418. After transfection of T-REx-293 cells with pTREx-mCherry-2A-Cdh3, individual clones were isolated and tested under induction with 1 μg/mL tetracycline (Sigma). Clone THAD3-34 was selected according to its fluorescence intensity and homogeneity, and is referred to as ‘P-cells’ in the main text of this report. We have described the similar production of clone THAD1-34, referred to as ‘E-cells’ in the main text, in a previous paper9 (link).
+ Open protocol
+ Expand
5

Recombinant Nipah Virus Glycoprotein Vaccine

Check if the same lab product or an alternative is used in the 5 most similar protocols
The glycoprotein (G) gene from Nipah virus (Bangladesh outbreak 2008–2010, Genbank accession number: JN808864.1) was codon optimized for humans and synthesized by GeneArt (Thermo Fisher Scientific‎). The synthesized G gene was cloned into a transgene expression plasmid comprising a modified human cytomegalovirus immediate early promoter (CMV promoter) with tetracycline operator (TetO) sites and the polyadenylation signal from bovine growth hormone (BGH). The resulting expression cassette was inserted into the E1 locus of a genomic clone of ChAdOx1 using site-specific recombination [25 (link)]. The virus was rescued and propagated in T-REx-293 cells (Invitrogen). Purification was by CsCl gradient ultracentrifugation, and the virus was titered as previously described [26 (link)]. Doses for vaccination were based on infectious units (IU).
+ Open protocol
+ Expand
6

Production of ChAdOx1 MERS-CoV Vaccine

Check if the same lab product or an alternative is used in the 5 most similar protocols
The S protein gene from MERS-CoV strain Camel/Qatar/2/2014 (GenBank accession no. KJ650098.1) was codon optimized for humans and synthesized by GeneArt (Thermo Fisher Scientific). The synthesized S gene was cloned into a transgene expression plasmid comprising a modified human cytomegalovirus immediate early promoter (CMV promoter) with tetracycline operator sites and the polyadenylation signal from bovine growth hormone. The resulting expression cassette was inserted into the E1 locus of a genomic clone of ChAdOx1 using site-specific recombination (31 (link)). The virus was rescued and propagated in T-REx-293 cells (Invitrogen). Purification was by CsCl gradient ultracentrifugation, and the virus was titered, as previously described (32 (link)). Doses for vaccination were based on infectious units (IUs) (33 (link)).
+ Open protocol
+ Expand
7

Polyglutamine Protein Aggregation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ability of DNAJB6 to prevent aggregation of polyQ-huntingtin was tested using filter-trap assay as described earlier [1 (link),5 (link),9 (link)] with minor modifications. In brief, T-REx 293 cells (Invitrogen) were grown at 37 °C, 5% CO2, in DMEM supplemented with 10% fetal bovine serum, GlutaMax, penicillin/streptomycin, and blasticidin S. The cells were transfected with GFP-tagged 120Q-HTT and inducible V5-tagged DNAJB6-constructs, expression of DNAJB6 induced after 5 h (or 4 h in experiments involving p.H31Q constructs) and the cells harvested 48 h post transfection. The soluble fraction of 120Q-HTT was measured using western blotting and the aggregates trapped in a 0.2 μm cellulose acetate filter (Whatman GmbH). The membranes and filters were stained for GFP (A-11122, Invitrogen) and V5 (R960-25, Invitrogen), scanned on an Odyssey scanner (LI-COR) and quantified using ImageStudio v. 3.1.4 (LI-COR) or ImageJ. The aggregation score was calculated from the intensities of aggregated and soluble GFP-HTT as (aggregated/soluble)induced/(aggregated/soluble)uninduced and statistical significance calculated using a two-tailed Mann–Whitney U test without multiple testing correction.
+ Open protocol
+ Expand
8

Cell Line Culture Conditions

Check if the same lab product or an alternative is used in the 5 most similar protocols
All cell lines were grown in medium supplemented with 10% foetal bovine serum (FBS, Pan Biotech), 100 units ml-1 of penicillin and 100 μg ml-1 of streptomycin (Gibco), at 37 °C in a humid atmosphere containing 5% CO2. Human embryo kidney (HEK) 293T cells (ATCC, CRL-11268) and monkey kidney BS-C-1 (ATCC, CCL-26) and CV-1 (ATCC, CCL-70) cells were grown in Dulbecco’s modified Eagle’s medium (DMEM, Gibco). Rabbit kidney RK13 cells (ATCC, CCL-37) were grown in minimum essential medium (MEM, Gibco) and human cervix HeLa cells (ATCC, CCL-2), in MEM supplemented with non-essential amino acids (Gibco). T-REx-293 cells (Invitrogen) were grown in DMEM supplemented with blasticidin (10 μg ml-1, InvivoGen), whilst the growth medium of T-REx-293-derived cell lines stably transfected with pcDNA4/TO-based plasmids was further supplemented with zeocin (100 μg ml-1, Gibco). The absence of mycoplasma contamination in the cell cultures was tested routinely with MycoAlert detection kit (Lonza), following the manufacturer’s recommendations.
+ Open protocol
+ Expand
9

Stable Transfection of T-REx-293 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
T-REx™-293 cells (Invitrogen R71007) were transfected with the plasmid pCDNA5-TO-h-SLC1A5 (Invitrogen V1033-20). The cloning sites consisted of Not1 and Xba; insert OriGene # SC116600. Stably transfected clones were selected via hygromycin (150 µg/ml).
+ Open protocol
+ Expand
10

Inducible Expression of Protein F14

Check if the same lab product or an alternative is used in the 5 most similar protocols
T-REx-293 cells (Invitrogen), which constitutively expresses the Tet repressor (TetR), were transfected with pcDNA4/TO-coF14-TAP plasmid, which encodes F14 under the control of the HCMV immediate early promoter and two tetracycline operator (TetO2) sites. Transfected cells were selected in the presence of blasticidin (10 μg ml-1) and zeocin (100 μg ml-1) and clonal cell lines were obtained by limiting dilution. Expression of protein F14 within these clones was analysed by immunoblotting and flow cytometry with anti-FLAG antibodies. T-REx-293-EV, T-REx-293-B14 and T-REx-293-C6 cell lines were described elsewhere21 (link).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!